Literature DB >> 19111580

Secondary lipid accumulation in lysosomal disease.

Steven U Walkley1, Marie T Vanier.   

Abstract

Lysosomal diseases are inherited metabolic disorders caused by defects in a wide spectrum of lysosomal and a few non-lysosomal proteins. In most cases a single type of primary storage material is identified, which has been used to name and classify the disorders: hence the terms sphingolipidoses, gangliosidoses, mucopolysaccharidoses, glycoproteinoses, and so forth. In addition to this primary storage, however, a host of secondary storage products can also be identified, more often than not having no direct link to the primary protein defect. Lipids - glycosphingolipids and phospholipids, as well as cholesterol - are the most ubiquitous and best studied of these secondary storage materials. While in the past typically considered nonspecific and nonconsequential features of these diseases, newer studies suggest direct links between secondary storage and disease pathogenesis and support the view that understanding all aspects of this sequestration process will provide important insights into the cell biology and treatment of lysosomal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19111580      PMCID: PMC4382014          DOI: 10.1016/j.bbamcr.2008.11.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  129 in total

1.  Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases.

Authors:  V Puri; R Watanabe; M Dominguez; X Sun; C L Wheatley; D L Marks; R E Pagano
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

Review 2.  Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.

Authors:  M T Vanier
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; N Gazzah; M C Juge; P G Pentchev; A Revol; P Louisot
Journal:  Biochim Biophys Acta       Date:  1991-06-05

4.  Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls.

Authors:  G Constantopoulos; A S Dekaban
Journal:  J Neurochem       Date:  1978-05       Impact factor: 5.372

5.  Embryonic striatal neurons from niemann-pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness.

Authors:  L P Henderson; L Lin; A Prasad; C A Paul; T Y Chang; R A Maue
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

Review 6.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

7.  Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues.

Authors:  G Constantopoulos; K Iqbal; A S Dekaban
Journal:  J Neurochem       Date:  1980-06       Impact factor: 5.372

8.  Progesterone blocks cholesterol translocation from lysosomes.

Authors:  J D Butler; J Blanchette-Mackie; E Goldin; R R O'Neill; G Carstea; C F Roff; M C Patterson; S Patel; M E Comly; A Cooney
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

9.  Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent.

Authors:  Marjorie C Gondré-Lewis; Robert McGlynn; Steven U Walkley
Journal:  Curr Biol       Date:  2003-08-05       Impact factor: 10.834

Review 10.  Gangliosides as apoptotic signals in ER stress response.

Authors:  A d'Azzo; A Tessitore; R Sano
Journal:  Cell Death Differ       Date:  2006-03       Impact factor: 15.828

View more
  96 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

2.  Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB.

Authors:  Sandrine Vitry; Julie Bruyère; Michaël Hocquemiller; Stéphanie Bigou; Jérôme Ausseil; Marie-Anne Colle; Marie-Christine Prévost; Jean Michel Heard
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

3.  Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders.

Authors:  Alessandro Fraldi; Fabio Annunziata; Alessia Lombardi; Hermann-Josef Kaiser; Diego Luis Medina; Carmine Spampanato; Anthony Olind Fedele; Roman Polishchuk; Nicolina Cristina Sorrentino; Kai Simons; Andrea Ballabio
Journal:  EMBO J       Date:  2010-09-24       Impact factor: 11.598

4.  A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts.

Authors:  Ulrike Schueler; Christine Kaneski; Alan Remaley; Stephen Demosky; Nancy Dwyer; Joan Blanchette-Mackie; John Hanover; Roscoe Brady
Journal:  JIMD Rep       Date:  2015-12-19

Review 5.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

6.  Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.

Authors:  Susi Anheuser; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2015-07-14       Impact factor: 5.922

7.  Generation of a human neuronal stable cell model for niemann-pick C disease by RNA interference.

Authors:  Laura Rodríguez-Pascau; Maria Josep Coll; Josefina Casas; Lluïsa Vilageliu; Daniel Grinberg
Journal:  JIMD Rep       Date:  2011-11-01

Review 8.  Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Authors:  Paul Helquist; Frederick R Maxfield; Norbert L Wiech; Olaf Wiest
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 9.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

10.  Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.

Authors:  Cristin D Davidson; Nafeeza F Ali; Matthew C Micsenyi; Gloria Stephney; Sophie Renault; Kostantin Dobrenis; Daniel S Ory; Marie T Vanier; Steven U Walkley
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.